ResMed

ResMed reported a revenue of 4,685,297,000 USD for the fiscal year 2026, marking a growth of 10.9%. The company's net income was 1,020,951,000 USD with a profit margin of 21.8%.

• ·Revenue increased by 10.9% from the previous fiscal year to reach $4.68 billion.
• ·Net income for the fiscal year was $1.02 billion, reflecting a strong financial performance.
• ·Profit margin stood at 21.8%, indicating efficient cost management and pricing strategies.